H1 FY27 Revenue Up 24.2% YoY to ₹51.07 Cr, Net Profit Rises 16% to ₹2.31 Cr
Paragon Fine and Speciality Chemical reported standalone revenue from operations of ₹51.07 crore for the half-year ended September 30, 2026, an increase of 24.2% YoY compared to ₹41.11 crore in H1 FY26. Net profit for the period rose 16.1% YoY to ₹2.31 crore against ₹1.99 crore in the corresponding previous half-year. Half-yearly EPS stood at ₹1.18 versus ₹1.02 in H1 FY26. Additionally, the company certified 100% utilization of its ₹51.66 crore IPO proceeds raised on the NSE SME platform.
உச்சம் நம்பிக்கை
என்ன மாறியதுParagon reported its unaudited standalone financial results for the half-year ended September 30, 2026, alongside confirmation of full utilization of IPO funds.
ஏன் இது முக்கியம்Top-line growth of 24% demonstrates steady volume expansion in chemical intermediates, though sequential performance moderated compared to H2 FY26 revenue of ₹68.88 crore.
Revenue from Operations (H1 FY27): ₹5,107.42 லட்சம்Net Profit (H1 FY27): ₹230.98 லட்சம்IPO Proceeds Fully Utilized: ₹5,166.00 லட்சம்H1 FY27 Revenue vs TTM Revenue: ~22.6%
📅 குறுகிய காலம்Results reflect steady YoY expansion on half-year basis, which provides fundamental support, though sequential contraction from H2 FY26 may temper immediate reactions.
📈 நீண்ட காலம்With IPO-funded capex of ₹7.87 crore for plant & machinery and civil work completed, capacity ramp-up and domestic demand tailwinds will determine multi-year earnings growth.
⚠ அபாய எச்சரிக்கைகள்
- Sequential decline in revenue and PAT relative to H2 FY26 (ended March 31, 2026)
- Raw material cost volatility impacting gross spreads
👀 கவனிக்க வேண்டியவை
Track margin progression and working capital turnover in the upcoming H2 FY27 results to see if top-line expansion translates into improved operating leverage.
